Midkine level may be used as a noninvasive biomarker in Crohn's disease

Kekilli M., Tanoglu A., Karaahmet F., Dogan Z., CAN M., Sayilir A., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.50, no.2, pp.324-329, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 50 Issue: 2
  • Publication Date: 2020
  • Doi Number: 10.3906/sag-1904-167
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.324-329
  • Çanakkale Onsekiz Mart University Affiliated: Yes

Abstract

Background/aim: Crohn's disease (CD) is a kind of inflammatory bowel disease. Midkine (MDK) is an endogenous inflammatory marker. We aimed to investigate the relationship between MDK levels and inflammation and hence determine whether MDK can be used as a noninvasive biomarker in active CD.